Cereno to Attend JPM Week & Biotech Showcase in San Francisco
12 Dec 2025 //
PR NEWSWIRE BIO
Cereno Scientific Cleared For Global Phase IIb Trial Of CS1
09 Dec 2025 //
PR NEWSWIRE
Cereno Scientific Submits CS1 Phase Iib Protocol For PAH To FDA
10 Nov 2025 //
PR NEWSWIRE
Cereno`s HDAC inhibitor reduces risks from PAH in phase 2 trial
30 Sep 2024 //
FIERCE BIOTECH
Cereno Scientific obtains first patent in Europe for drug candidate CS585
23 Sep 2022 //
CISION
Cereno broadens patent protection for drug candidate CS585
09 Sep 2022 //
CISION

Market Place
Sourcing Support